Advertisement

Factors Influencing Participation in Alzheimer’s Disease Clinical Trials

The rate of diagnosis for Alzheimer’s disease (AD) has continued to grow, and AD has a significant impact on the economy, costing...

Remote Clinical Trial Enrollment Program Is Valuable in the Face of COVID-19

Conventional recruitment and outreach events often involve direct contact with potential participants during memory clinics, brain health check-ins, or health fairs. The...

Literature Review Underscores the Need for Appropriate Treatments for Dementia-Related Psychosis

There currently are no FDA-approved treatments for dementia-related psychosis; however, antipsychotics are often used to treat its symptoms. Atypical antipsychotics (AAPs) have...

Pimavanserin Associated with Limited Antipsychotic-Related Adverse Events

A study assessed the incidence of adverse events (AEs) associated with pimavanserin, a selective serotonin inverse agonist/antagonist, and found that the incidence...
Advertisement